ARCHIVES

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB Schedules Full Day Of AIDS Discussion; PBS To Show Documentary On Tobacco Issues

November 6, 1987

ECOG, ACRIN Form Single Cooperative Group

May 18, 2012

Missouri Center Director Search Narrowed To Vincent, Wiernik

September 10, 1982

Medicare coverage and quality of care top ASCO’s list of policy priorities for 2004.

February 27, 2004

In Brief: ASTRO Elects New Officers; ASSIST Coordinators Express Concern Over NCI Plan To Cut Budget

November 27, 1992

NCI To Seek Cancer Act Changes On Center Grant Limits

April 9, 1976